153 related articles for article (PubMed ID: 24528038)
1. Ellagic acid exerts anti-proliferation effects via modulation of Tgf-β/Smad3 signaling in MCF-7 breast cancer cells.
Zhang T; Chen HS; Wang LF; Bai MH; Wang YC; Jiang XF; Liu M
Asian Pac J Cancer Prev; 2014; 15(1):273-6. PubMed ID: 24528038
[TBL] [Abstract][Full Text] [Related]
2. Ellagic acid induces cell cycle arrest and apoptosis through TGF-β/Smad3 signaling pathway in human breast cancer MCF-7 cells.
Chen HS; Bai MH; Zhang T; Li GD; Liu M
Int J Oncol; 2015 Apr; 46(4):1730-8. PubMed ID: 25647396
[TBL] [Abstract][Full Text] [Related]
3. Ellagic acid induces cell cycle arrest and apoptosis via the TGF‑β1/Smad3 signaling pathway in human colon cancer HCT‑116 cells.
Zhao J; Li G; Wei J; Dang S; Yu X; Ding L; Shang C; Zhang H; Zhang Z; Chen H; Liu M
Oncol Rep; 2020 Aug; 44(2):768-776. PubMed ID: 32468010
[TBL] [Abstract][Full Text] [Related]
4. Characterization of SIS3, a novel specific inhibitor of Smad3, and its effect on transforming growth factor-beta1-induced extracellular matrix expression.
Jinnin M; Ihn H; Tamaki K
Mol Pharmacol; 2006 Feb; 69(2):597-607. PubMed ID: 16288083
[TBL] [Abstract][Full Text] [Related]
5. Specific Inhibitor of Smad3 (SIS3) Attenuates Fibrosis, Apoptosis, and Inflammation in Unilateral Ureteral Obstruction Kidneys by Inhibition of Transforming Growth Factor β (TGF-β)/Smad3 Signaling.
Ji X; Wang H; Wu Z; Zhong X; Zhu M; Zhang Y; Tan R; Liu Y; Li J; Wang L
Med Sci Monit; 2018 Mar; 24():1633-1641. PubMed ID: 29555895
[TBL] [Abstract][Full Text] [Related]
6. Nox4 involvement in TGF-beta and SMAD3-driven induction of the epithelial-to-mesenchymal transition and migration of breast epithelial cells.
Boudreau HE; Casterline BW; Rada B; Korzeniowska A; Leto TL
Free Radic Biol Med; 2012 Oct; 53(7):1489-99. PubMed ID: 22728268
[TBL] [Abstract][Full Text] [Related]
7. C-reactive protein promotes acute kidney injury via Smad3-dependent inhibition of CDK2/cyclin E.
Lai W; Tang Y; Huang XR; Ming-Kuen Tang P; Xu A; Szalai AJ; Lou TQ; Lan HY
Kidney Int; 2016 Sep; 90(3):610-26. PubMed ID: 27470679
[TBL] [Abstract][Full Text] [Related]
8. The preventive and therapeutic implication for renal fibrosis by targetting TGF-β/Smad3 signaling.
Zhang Y; Meng XM; Huang XR; Lan HY
Clin Sci (Lond); 2018 Jul; 132(13):1403-1415. PubMed ID: 29875262
[TBL] [Abstract][Full Text] [Related]
9. The proinflammatory LTB4/BLT1 signal axis confers resistance to TGF-β1-induced growth inhibition by targeting Smad3 linker region.
Jeon WK; Choi J; Park SJ; Jo EJ; Lee YK; Lim S; Kim JH; Letterio JJ; Liu F; Kim SJ; Kim BC
Oncotarget; 2015 Dec; 6(39):41650-66. PubMed ID: 26497676
[TBL] [Abstract][Full Text] [Related]
10. Curcumin and emodin down-regulate TGF-β signaling pathway in human cervical cancer cells.
Thacker PC; Karunagaran D
PLoS One; 2015; 10(3):e0120045. PubMed ID: 25786122
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of transforming growth factor β1/Smad3 signaling decreases hypoxia-inducible factor-1α protein stability by inducing prolyl hydroxylase 2 expression in human periodontal ligament cells.
Watanabe T; Yasue A; Tanaka E
J Periodontol; 2013 Sep; 84(9):1346-52. PubMed ID: 23088526
[TBL] [Abstract][Full Text] [Related]
12. Yap1 promotes the survival and self-renewal of breast tumor initiating cells via inhibiting Smad3 signaling.
Sun JG; Chen XW; Zhang LP; Wang J; Diehn M
Oncotarget; 2016 Mar; 7(9):9692-706. PubMed ID: 26695440
[TBL] [Abstract][Full Text] [Related]
13. A small-molecule inhibitor of SMAD3 attenuates resistance to anti-HER2 drugs in HER2-positive breast cancer cells.
Chihara Y; Shimoda M; Hori A; Ohara A; Naoi Y; Ikeda JI; Kagara N; Tanei T; Shimomura A; Shimazu K; Kim SJ; Noguchi S
Breast Cancer Res Treat; 2017 Nov; 166(1):55-68. PubMed ID: 28702892
[TBL] [Abstract][Full Text] [Related]
14. Platelet-Derived Growth Factor and Transforming Growth Factor β1 Regulate ARDS-Associated Lung Fibrosis Through Distinct Signaling Pathways.
Deng X; Jin K; Li Y; Gu W; Liu M; Zhou L
Cell Physiol Biochem; 2015; 36(3):937-46. PubMed ID: 26088859
[TBL] [Abstract][Full Text] [Related]
15. The loss of Trps1 suppresses ureteric bud branching because of the activation of TGF-β signaling.
Gui T; Sun Y; Gai Z; Shimokado A; Muragaki Y; Zhou G
Dev Biol; 2013 May; 377(2):415-27. PubMed ID: 23537899
[TBL] [Abstract][Full Text] [Related]
16. Homoharringtonine targets Smad3 and TGF-β pathway to inhibit the proliferation of acute myeloid leukemia cells.
Chen J; Mu Q; Li X; Yin X; Yu M; Jin J; Li C; Zhou Y; Zhou J; Suo S; Lu D; Jin J
Oncotarget; 2017 Jun; 8(25):40318-40326. PubMed ID: 28454099
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-β1 mediates psoriasis-like lesions via a Smad3-dependent mechanism in mice.
Zhang Y; Meng XM; Huang XR; Wang XJ; Yang L; Lan HY
Clin Exp Pharmacol Physiol; 2014 Nov; 41(11):921-32. PubMed ID: 25132073
[TBL] [Abstract][Full Text] [Related]
18. Role of Transforming Growth Factor-β1 and Smads Signaling Pathway in Intrauterine Adhesion.
Salma U; Xue M; Ali Sheikh MS; Guan X; Xu B; Zhang A; Huang L; Xu D
Mediators Inflamm; 2016; 2016():4158287. PubMed ID: 26997760
[TBL] [Abstract][Full Text] [Related]
19. Anti-tumor activity of SL4 against breast cancer cells: induction of G
Wang LH; Jiang XR; Chen GL; Guo W; Zhang JY; Cui LJ; Li HH; Li M; Liu X; Yang JY; Wu CF
Sci Rep; 2016 Nov; 6():36486. PubMed ID: 27819344
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic effects of conditioned medium from bone marrow-derived mesenchymal stem cells on epithelial-mesenchymal transition in A549 cells.
Wang X; Gao JL; Zhao MM; Zhu HX; Tian YX; Li R; Jiang XH; Yu L; Tian JR; Cui JZ
Int J Mol Med; 2018 Feb; 41(2):659-668. PubMed ID: 29207055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
